wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33373033-9838C9B5-82E9-45AB-9314-6E71EB379A24
Q33373033-9838C9B5-82E9-45AB-9314-6E71EB379A24
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33373033-9838C9B5-82E9-45AB-9314-6E71EB379A24
High efficacy and safety profile of fractionated doses of Mylotarg as induction therapy in patients with relapsed acute myeloblastic leukemia: a prospective study of the alfa group.
P2860
Q33373033-9838C9B5-82E9-45AB-9314-6E71EB379A24
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33373033-9838C9B5-82E9-45AB-9314-6E71EB379A24
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1462ee53b0a0d49ebcbf69225dddf34c5584158c
P2860
Mylotarg (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation